ReviewJournal of the International AIDS Society2023
Mobility and HIV care engagement: a research agenda.
Review in Journal of the International AIDS Society, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed.
- Residential mobility and health among people with HIV: a scoping review.AIDS (London, England) · 2026Article
- The Role of Mobility in HIV Intervention Engagement and Community Mobilization among Female Sex Workers Living with HIV in the Dominican Republic.AIDS and behavior · 2026Article
- Geostatistical point process modelling of HIV prevalence using disease progression and CD4 cell count dynamics.iScience · 2026Article
- Beyond knowledge deficits: social visibility, family dynamics, and delayed initiation among people living with HIV in Southwestern China-a descriptive phenomenological study.BMC public health · 2026Article
- Decadal trends in HIV prevalence among socio-demographic groups and health behaviours in Ethiopia: a cross-sectional seroprevalence study.BMC infectious diseases · 2026Article
- Perspectives on the Impacts of a Food Support Program on the Well-Being of People Living With HIV (PLHIV) and on Antiretroviral Therapy (ART) in Khomas Region, Namibia.AIDS research and treatment · 2026Article
- Migration and its impact on universal HIV testing and treatment in the HPTN 071 (PopART) study communities.PLOS global public health · 2026Article
- Article
- Coercive public health policies need context-specific ethical justifications.Monash bioethics review · 2025Article
- At a crossroads: confronting setbacks and advancing the 95-95-95 HIV targets in sub-Saharan Africa.AIDS research and therapy · 2025Review
- Metrics of Mobility by Sex are Associated with HIV Incidence in Rural Kenya and Uganda.AIDS and behavior · 2025Article
- Leveraging Smartphone Mobility Data to Understand HIV Risk Among Rural South African Young Adults: Feasibility Study.JMIR mHealth and uHealth · 2025Article
- Measuring mobility in HIV research in sub-Saharan Africa: a scoping review.Journal of the International AIDS Society · 2025Article
- HIV Care for Men on the Move: A Qualitative Study to Inform Status-Neutral HIV Service Delivery for Mobile Men in Johannesburg, South Africa.AIDS and behavior · 2025Article
- Navigating HIV care in a mobile society: case studies of clinic transfers in South Africa's public health sector.AIDS care · 2025Article
- Transition to Adult Care for Young People Living with HIV.Current HIV/AIDS reports · 2025Review
- To what extent are digital health interventions targeting HIV care cascade among mobile populations feasible, acceptable, and effective? A mixed methods systematic review protocol.Systematic reviews · 2025Article
- Applying implementation science frameworks to understand why fisherfolk continue or discontinue pre-exposure prophylaxis for HIV prevention in Uganda: a qualitative analysis.BMJ global health · 2025Article
- HIV services for fisherfolk in Sierra Leone: A formative assessment of barriers, opportunities, and community preferences.PLOS global public health · 2025Article
- A Scoping Review of Factors Associated with HIV Acquisition in the Context of Humanitarian Crises.AIDS and behavior · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
introductionMobility is common and an essential livelihood strategy in sub-Saharan Africa (SSA). Mobile people suffer worse outcomes at every stage of the HIV care cascade compared to non-mobile populations. Definitions of mobility vary widely, and research on the role of temporary mobility (as opposed to permanent migration) in HIV treatment outcomes is often lacking. In this article, we review the current landscape of mobility and HIV care research to identify what is already known, gaps in the literature, and recommendations for future research. DISCUSSION: Mobility in SSA is closely linked to income generation, though caregiving, climate change and violence also contribute to the need to move. Mobility is likely to increase in the coming decades, both due to permanent migration and increased temporary mobility, which is likely much more common. We outline three central questions regarding mobility and HIV treatment outcomes in SSA. First, it is unclear what aspects of mobility matter most for HIV care outcomes and if high-risk mobility can be identified or predicted, which is necessary to facilitate targeted interventions for mobile populations. Second, it is unclear what groups are most vulnerable to mobility-associated treatment interruption and other adverse outcomes. And third, it is unclear what interventions can improve HIV treatment outcomes for mobile populations.
conclusionsMobility is essential for people living with HIV in SSA. HIV treatment programmes and broader health systems must understand and adapt to human mobility, both to promote the rights and welfare of mobile people and to end the HIV pandemic.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.